Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

2.800

-0.030 (-1.06%)

At close: Sep 17, 2025, 4:00 PM EDT

2.820

+0.020 (0.71%)

After-hours: Sep 17, 2025, 4:49 PM EDT

Akebia Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-36.48	-69.41	-51.93	-94.23	-282.02	-384.84
Depreciation & Amortization	23.55	41.7	41.85	37.7	37.97	34.69
Loss (Gain) From Sale of Assets	-0.17	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	0.78	8.77	-	114.43
Loss (Gain) From Sale of Investments	-	-	-	-	-0.02	-0.05
Stock-Based Compensation	8.21	7.78	9.32	17.85	22.74	24.46
Provision & Write-off of Bad Debts	1.84	0.88	-	-	-	-
Other Operating Activities	36.18	18.07	-2.68	-41.8	73.98	113.78
Change in Accounts Receivable	-44.88	4.05	0.99	11.3	-24.03	11.67
Change in Inventory	-21.65	-28.4	-2.54	19.09	-24.95	6.16
Change in Accounts Payable	0.85	-1.36	-5.24	1.5	-11.74	3.68
Change in Unearned Revenue	5.53	-	-3.74	4.65	1.82	-32.39
Change in Other Net Operating Assets	24.63	-13.96	-10.2	-37.98	-46.72	-1.97
Operating Cash Flow	-2.4	-40.66	-23.38	-73.15	-252.97	-110.39
Capital Expenditures	-0.15	-0.03	-	-0.11	-0.06	-0.32
Investment in Securities	-	-	-	-	40	-39.69
Investing Cash Flow	0.02	-0.03	-	-0.11	39.94	-40
Long-Term Debt Issued	-	45	-	-	-	19.98
Long-Term Debt Repaid	-	-37.1	-32	-33	-	-
Net Debt Issued (Repaid)	9.54	7.9	-32	-33	-	19.98
Issuance of Common Stock	91.26	43.03	6.79	7.6	88.95	211.75
Other Financing Activities	-0.59	-1.27	-	40	44.78	-
Financing Cash Flow	100.21	49.66	-25.21	14.6	133.73	231.72
Net Cash Flow	97.83	8.97	-48.59	-58.67	-79.29	81.33
Free Cash Flow	-2.55	-40.69	-23.38	-73.27	-253.02	-110.71
Free Cash Flow Margin	-1.25%	-25.40%	-12.02%	-25.05%	-119.55%	-37.57%
Free Cash Flow Per Share	-0.01	-0.19	-0.13	-0.40	-1.52	-0.80
Cash Interest Paid	5.04	5.04	6.06	6.76	9.63	7.84
Levered Free Cash Flow	-7.42	17.83	22.11	-15.3	-136.04	-17.99
Unlevered Free Cash Flow	10.17	29.2	25.88	-5.5	-123.53	-12.42
Change in Working Capital	-35.51	-39.68	-20.73	-1.44	-105.61	-12.86

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q